Treatment or surveillance for CIN2?: Women now have better data on regression and progression to help them decide

Margaret Cruickshank

doi:10.1136/bmj.k771

Treatment or surveillance for CIN2? Women now have better data on regression and progression to help them decide

Margaret Cruickshank

Medical Education

Research output: Contribution to journal › Editorial

3 Citations (Scopus)

8 Downloads (Pure)

Original language	English
Article number	k771
Pages (from-to)	1-2
Number of pages	2
Journal	BMJ
Volume	360
DOIs	https://doi.org/10.1136/bmj.k771
Publication status	Published - 27 Feb 2018

Keywords

Editorial

Access to Document

10.1136/bmj.k771Licence: Unspecified

Treatment or surveillance for CIN2?
For all Publisher commissioned articles, the right to post a version of the final published version of the Contribution, or any abstract of the final published Contribution on the Contributor(s)’s own and/or his/her institution’s website 12 months after publication. This article has been published in the BMJ, Cruickshank Maggie. Treatment or surveillance for CIN2? BMJ 2018; 360 :k771 and can also be viewed on the journal’s website at www.bmj.com
Final published version, 812 KBLicence: Other

Cite this

@article{902a20a2621a408fb72410d0ff3b0ed4,

title = "Treatment or surveillance for CIN2?: Women now have better data on regression and progression to help them decide",

keywords = "Editorial",

author = "Margaret Cruickshank",

note = "Acknowledgments Jaimie Kavanagh reviewed and contributed to this editorial as a patient representative and volunteer for Jo{\textquoteright}s Cervical Cancer Trust.",

year = "2018",

month = feb,

day = "27",

doi = "10.1136/bmj.k771",

language = "English",

volume = "360",

pages = "1--2",

journal = "BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Treatment or surveillance for CIN2?

T2 - Women now have better data on regression and progression to help them decide

AU - Cruickshank, Margaret

N1 - Acknowledgments Jaimie Kavanagh reviewed and contributed to this editorial as a patient representative and volunteer for Jo’s Cervical Cancer Trust.

PY - 2018/2/27

Y1 - 2018/2/27

KW - Editorial

U2 - 10.1136/bmj.k771

DO - 10.1136/bmj.k771

M3 - Editorial

C2 - 29487080

VL - 360

SP - 1

EP - 2

JO - BMJ

JF - BMJ

SN - 0959-8146

M1 - k771

ER -